Chronic Obstructive Pulmonary Disease
📧 Sign up to get email alerts when something new happens for Chronic Obstructive Pulmonary Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: The Effects of Simvastatin on Th17 Cytokines and Th17 Polarizing Cytokine in COPD Patients [Phase 3]
Phase 3 trial evaluating the effects of simvastatin on Th17 cytokines in chronic obstructive pulmonary disease has completed.
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Genetics of Airway Responsiveness and Lung Function
A completed NHLBI-funded clinical trial investigates how genetics influence airway responsiveness and lung function in asthma and obstructiv…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Statistical Analysis of Vlagtwedde-Vlaardingen Data Set
This completed NHLBI-sponsored analysis re-examines the Vlagtwedde-Vlaardingen cohort data to explore asthma and obstructive lung diseases.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Early Risk Predictors For Chronic Pulmonary Disease
This NHLBI-sponsored clinical trial update reports on early risk predictors for chronic pulmonary disease and is marked as completed. It inv…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Effect of Maternal Smoking On Neonatal Lung Function
NHLBI-sponsored clinical trial examining the effect of maternal smoking on neonatal lung function has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Chronic Obstructive Pulmonary Disease as a Predictor of Mortality in Cardiac Surgery
Clinical trial update examining whether Chronic Obstructive Pulmonary Disease predicts mortality in patients undergoing cardiac surgery; cur…
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Assessing the Occupation Burden in COPD
NHLBI-sponsored clinical trial update evaluating the impact of chronic obstructive pulmonary disease on occupational burden; the study statu…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Diet and Chronic Obstructive Pulmonary Disease
An NHLBI-sponsored clinical trial studying the effects of diet on Chronic Obstructive Pulmonary Disease has completed.
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Epidemiology of Airway Responsiveness
This clinical trials update describes the completed study NCT00005284 on the epidemiology of airway responsiveness in asthma and obstructive…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Prognosis and Treatment of COPD in Primary Care-use of Biomarkers
This clinical trial update investigates prognosis and treatment of Chronic Obstructive Pulmonary Disease in primary care using biomarkers. T…
-
CLINICAL_TRIALS trial_result · 2016-03-07Clinical Trial Update: Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
Phase 3 trial comparing aclidinium bromide/formoterol fumarate with salmeterol/fluticasone propionate in COPD has completed and results have…
-
FDA approval · 2016-03-03FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for albuterol sulfate from Sandoz Inc, updating the product labeling.
-
CLINICAL_TRIALS trial_result · 2016-03-03Clinical Trial Update: Comparative Study of Umeclidinium/Vilanterol (UMEC/VI) in a Fixed Dose Combination With Indacaterol Plus Tiotropium [Phase 3]
Phase 3 trial update reporting results of a fixed-dose combination of umeclidinium/vilanterol with indacaterol plus tiotropium in COPD. The …
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Effects of Chronic Ozone Exposure on Lung Function
This clinical trial update indicates that a NHLBI-sponsored study examining the effects of chronic ozone exposure on lung function has compl…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Evaluation of a Lightweight Nasal Interface and Ventilator in Patients With Respiratory Disease [NA]
A clinical trial update describes evaluating a lightweight nasal interface and ventilator for patients with chronic respiratory diseases, sp…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Tucson Epidemiology Study of Chronic Obstructive Lung Diseases
The Tucson Epidemiology Study of Chronic Obstructive Lung Diseases, sponsored by NHLBI, is a completed trial evaluating asthma, bronchitis, …
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: The Purpose of the This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotropium 18mcg Once Daily Over a a 12-week Treatment Period in Subjects With COPD Who Continue to Have Symptoms on Tiotropium [Phase 3]
Phase 3 trial comparing umeclidinium/vilanterol 62.5/25 mcg once daily to tiotropium 18 mcg once daily over 12 weeks in COPD patients with o…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]
A Phase IIIb clinical trial evaluating the efficacy of umeclidinium/vilanterol (UMEC/VI) in chronic obstructive pulmonary disease has comple…
-
CLINICAL_TRIALS withdrawal · 2016-02-25Clinical Trial Update: Withdrawal of Inhaled Corticosteroids in Primary Care Patients With COPD [NA]
This update summarizes a trial investigating withdrawal of inhaled corticosteroids in primary care patients with chronic obstructive pulmona…
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Effects of Ergometer Training With Telemonitoring in Patients With Chronic Obstructive Pulmonary Disease (COPD) After Exacerbation [NA]
The trial assessed the effects of ergometer training with telemonitoring in patients with COPD after an exacerbation. The study has complete…
-
CLINICAL_TRIALS research · 2016-02-25Clinical Trial Update: Electrical Stimulation for Attenuating Muscle Atrophy [NA]
Clinical trial investigating electrical stimulation to attenuate muscle atrophy in chronic obstructive pulmonary disease; the current trial …
-
FDA approval · 2016-02-24FDA Approved: UMECLIDINIUM AND VILANTEROL ELLIPTA — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application from Prasco Laboratories for umeclidinium bromide and vilanterol trifenatate in the Ellipta inhaler.…
-
FDA approval · 2016-02-24FDA Approved: INCRUSE ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for Incruse Ellipta (umeclidinium) from GlaxoSmithKline LLC. The action represents a supplemental ap…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease [NA]
A completed clinical trial explored cardiorespiratory responses to whole body vibration training in patients with chronic lung disease (COPD…
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: Continuous Versus Interval Walking Training in Patients With COPD - a Pilot Study [NA]
A pilot study comparing continuous walking training to interval walking training in patients with chronic obstructive pulmonary disease to e…